Search results
Results from the WOW.Com Content Network
J&J has announced plans to finalize a $6.48 billion global settlement through the bankruptcy of a subsidiary company, after earlier efforts were rebuffed twice by federal courts. J&J says the ...
A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an approximately $8 billion proposed settlement that would end tens of ...
J&J's third attempt at bankruptcy protection involves a subsidiary called Red River Talc that would cap settlement damages at $8 billion. The company maintains that none of the talc-related claims ...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 1 reporter's record daily copy volume 2 cause no. d-1-gv-04-001288 state of texas, ) in the district ...
(Quarterly Report) Filed 11/04/08 for the Period Ending 09/28/08 Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK, NJ 08933 Telephone 732-524-2455 CIK 0000200406
ARNOLD & ITKIN, LLP BY: JASON A. ITKIN, ESQUIRE E-mail: jitkin@arnolditkin.com 6009 Memorial Drive Houston, Texas 77007 Phone: 713-222-3800 Fax: 713-222-3850 Counsel for Plaintiff(s) DRINKER BIDDLE & REATH, LLP BY: KENNETH A. MURPHY, ESQUIRE MELISSA A. GRAFF, ESQUIRE One Logan Square, Suite 2000
The cancer victims sought a preliminary order in New Jersey on June 11 to preventing J&J from filing for bankruptcy outside the state, which would have effectively foiled the $6.48 billion ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...